Jason Haas

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
18 Nov 24	SYRS Syros Pharmaceuticals	Common Stock	Sell	Dispose S	No	No	0.2103	137,803	28.98 k	0
31 Oct 24	SYRS Syros Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	2.09	5,624	11.75 k	137,803
31 Oct 24	SYRS Syros Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	0	18,875	0.00	143,427
31 Oct 24	SYRS Syros Pharmaceuticals	RSU Common Stock	Option exercise	Dispose M	No	No	0	18,875	0.00	0
12 Sep 24	SYRS Syros Pharmaceuticals	Common Stock	Buy	Acquire P	No	No	1.6762	45,344	76.01 k	124,552
11 Sep 24	SYRS Syros Pharmaceuticals	Common Stock	Buy	Acquire P	No	No	1.5781	19,293	30.45 k	79,208
10 Sep 24	SYRS Syros Pharmaceuticals	Common Stock	Buy	Acquire P	No	No	1.5493	35,363	54.79 k	59,915
14 Jun 24	LGND Ligand Pharmaceuticals	Common Stock	Grant	Acquire A	No	No	0	1,252	0.00	5,397
14 Jun 24	LGND Ligand Pharmaceuticals	NQSO Common Stock	Grant	Acquire A	No	No	80.06	5,444	435.85 k	5,444
1 Apr 24	SYRS Syros Pharmaceuticals	Common Stock	Payment of exercise	Dispose F	No	No	5.12	4,732	24.23 k	24,552

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.